Beryl Drugs will hold a meeting of the Board of Directors of the Company on 20 April 2024.Powered by Capital Market - Live News

Net profit of Beryl Drugs rose 121.43% to Rs 0.31 crore in the quarter ended December 2023 as against Rs 0.14 crore during the previous quarter ended December 2022. Sales declined 6.50% to Rs 7.62 crore in the quarter ended December 2023 as against Rs 8.15 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales7.628.15 -7 OPM %10.378.71 - PBDT0.680.59 15 PBT0.370.37 0 NP0.310.14 121 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 12 February 2024. The meeting would commence at 2.00 pm.Powered by Capital Market - Live News

Net profit of Beryl Drugs declined 20.59% to Rs 0.27 crore in the quarter ended September 2023 as against Rs 0.34 crore during the previous quarter ended September 2022. Sales rose 4.42% to Rs 8.03 crore in the quarter ended September 2023 as against Rs 7.69 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales8.037.69 4 OPM %8.978.06 - PBDT0.620.51 22 PBT0.330.32 3 NP0.270.34 -21 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News